CA2159355A1 - Methode et composition pour le traitement de l'osteoporose - Google Patents

Methode et composition pour le traitement de l'osteoporose

Info

Publication number: CA2159355A1
Authority: CA; Canada
Prior art keywords: osteoporosis; bicarbonate; treatment; composition; potassium
Prior art date: 1993-04-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

CA002159355A

Other languages

English (en)

Other versions

CA2159355C (fr

Inventor

R. Curtis Morris Jr.

Anthony Sebastian

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of California San Diego UCSD

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-04-02

Filing date

1994-03-29

Publication date

1994-10-13

1994-03-29 Application filed by Individual filed Critical Individual

1994-03-29 Priority claimed from PCT/US1994/003403 external-priority patent/WO1994022312A1/fr

1994-10-13 Publication of CA2159355A1 publication Critical patent/CA2159355A1/fr

2006-12-12 Application granted granted Critical

2006-12-12 Publication of CA2159355C publication Critical patent/CA2159355C/fr

2014-03-29 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

208000001132 Osteoporosis Diseases 0.000 title abstract 2
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 abstract 1
229940121792 Thiazide diuretic Drugs 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
150000001735 carboxylic acids Chemical class 0.000 abstract 1
239000012530 fluid Substances 0.000 abstract 1
-1 hydroxyl ions Chemical class 0.000 abstract 1
238000001727 in vivo Methods 0.000 abstract 1
XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 abstract 1
229910000028 potassium bicarbonate Inorganic materials 0.000 abstract 1
235000015497 potassium bicarbonate Nutrition 0.000 abstract 1
239000011736 potassium bicarbonate Substances 0.000 abstract 1
TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 abstract 1
159000000001 potassium salts Chemical class 0.000 abstract 1
239000003451 thiazide diuretic agent Substances 0.000 abstract 1
210000002700 urine Anatomy 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Inorganic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

CA002159355A 1993-04-02 1994-03-29 Methode et composition pour le traitement de l'osteoporose Expired - Fee Related CA2159355C (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US4229693A	1993-04-02	1993-04-02
US08/042,296		1993-04-02
PCT/US1994/003403 WO1994022312A1 (fr)	1993-04-02	1994-03-29	Procede et composition s'appliquant au traitement de l'osteoporose

Publications (2)

Publication Number	Publication Date
CA2159355A1 true CA2159355A1 (fr)	1994-10-13
CA2159355C CA2159355C (fr)	2006-12-12

Family

ID=37561027

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002159355A Expired - Fee Related CA2159355C (fr)	1993-04-02	1994-03-29	Methode et composition pour le traitement de l'osteoporose

Country Status (1)

Country	Link
CA (1)	CA2159355C (fr)

1994
- 1994-03-29 CA CA002159355A patent/CA2159355C/fr not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2159355C (fr)	2006-12-12

Similar Documents

Publication	Publication Date	Title
Balaji et al.	1997	Mechanism of stone formation
CA2027753A1 (fr)	1991-04-24	Compositions desodorisantes et nettoyantes et methode connexe
CA2172493A1 (fr)	1995-03-30	Utilisation d'angiotensine iii et de leurs analogues pour la reparation des tissus
CA2246373A1 (fr)	1997-08-21	Procede de decontamination
CA2158638A1 (fr)	1994-09-29	Composition et methode d'augmentation tissulaire
CA2337113A1 (fr)	2000-01-27	Procedes et dispositifs pour reduire la teneur en mineraux de lesions vasculaires calcifiees
IL117882A0 (en)	1996-08-04	Dermatological preparation and method of treating actinic keratoses
EP0103947A3 (fr)	1985-03-27	Procédé pour empêcher la minéralisation de tissu naturel lors de l'implantation
FR2705235B1 (fr)	1995-07-13	Utilisation de particules d'un sel de calcium biocompatible et biorésorbable comme ingrédient actif dans la préparation d'un médicament destiné au traitement local des maladies déminéralisantes de l'os.
CA2147281A1 (fr)	1994-04-28	Methode et compositions pour eliminer un alginate d'un substrat cutane
MY109531A (en)	1997-02-28	Effervescent antacid
CA1279572C (fr)	1991-01-29	Composition et methode pour la reparation de matiere osseuse
CA2034912A1 (fr)	1991-07-27	Composition deglacante inhibitrice de corrosion et methode d'utilisation
EP0357238A3 (fr)	1990-08-22	Composition antimicrobienne
AU1318095A (en)	1995-07-17	Composition for treating water and sanitising soils
WO1996010409A3 (fr)	1996-07-11	Compositions liquides antiacides contenant du carbonate de calcium et eventuellement de la simethicone comme composes actifs et du phosphate de potassium et du bicarbonate de potassium comme tampon
CA2159355A1 (fr)	1994-10-13	Methode et composition pour le traitement de l'osteoporose
EP0691814A4 (fr)	1998-09-23	Procede et composition s'appliquant au traitement de l'osteoporose
US5389678A (en)	1995-02-14	Soluble aluminum carboxylate bathing preparation
Lineberry et al.	1979	Acidosis inhibits the hypocalcemic effect of acetazolamide.
TW253837B (fr)	1995-08-11
ES2028275T3 (es)	1992-07-01	Un agente de curtido.
EP0417209A4 (en)	1992-01-08	Compositions and methods for administering therapeutically active compounds
JPS5799168A (en)	1982-06-19	Method for improving palatability of yuba
Ravichandran et al.	1994	Electrochemical behavior of 316 L stainless steel implant material under the influence of serum protein and calcium phosphate

Legal Events

Date	Code	Title	Description
2001-03-28	EEER	Examination request
2009-03-30	MKLA	Lapsed